SCOPUS 정보 검색 플랫폼

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 5, 2008, Pages 555-556

Inhaled corticosteroids and pneumonia in COPD: An association looking for evidence

(1) Turner, Mark O a

a UNIVERSITY OF BRITISH COLUMBIA (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; STEROID; THEOPHYLLINE; GLUCOCORTICOID;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; LETTER; LOWER RESPIRATORY TRACT INFECTION; MORTALITY; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; CANADA; EPIDEMIOLOGY; INHALATIONAL DRUG ADMINISTRATION; NOTE; RISK ASSESSMENT; STATISTICS;

ADMINISTRATION, INHALATION; CONFOUNDING FACTORS (EPIDEMIOLOGY); GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUEBEC; RISK ASSESSMENT;

EID: 40649114516 PISSN: 1073449X EISSN: 15354970 Source Type: Journal
DOI: 10.1164/ajrccm.177.5.555b Document Type: Letter

Times cited : (2)

References (6)

1
- 34447310860
- Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia
- Ernst P, Gonzalez AV, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007;176:162-166.
- (2007) Am J Respir Crit Care Med , vol.176 , pp. 162-166
- Ernst, P.¹ Gonzalez, A.V.² Brassard, P.³ Suissa, S.⁴

2
- 33847172367
- TORCH Investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
- Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH Investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789.
- (2007) N Engl J Med , vol.356 , pp. 775-789
- Calverley, P.M.A.¹ Anderson, J.A.² Celli, B.³ Ferguson, G.T.⁴ Jenkins, C.⁵ Jones, P.W.⁶ Yates, J.C.⁷ Vestbo, J.⁸

3
- 33846318149
- Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
- Kardos P, Wencker M, Glaab T, Vogelmeier C. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:144-149.
- (2007) Am J Respir Crit Care Med , vol.175 , pp. 144-149
- Kardos, P.¹ Wencker, M.² Glaab, T.³ Vogelmeier, C.⁴

4
- 0029834111
- 2-agonists
- 2-agonists. Am J Epidemiol 1996;144:1161-1169.
- (1996) Am J Epidemiol , vol.144 , pp. 1161-1169
- Blais, L.¹ Ernst, P.² Suissa, S.³

5
- 0029845475
- Risk of severe life threatening asthma and beta agonist type: An example of confounding by severity
- Garrett JE, Lanes SF, Kolbe J, Rea HH. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. Thorax 1996;51:1093-1099.
- (1996) Thorax , vol.51 , pp. 1093-1099
- Garrett, J.E.¹ Lanes, S.F.² Kolbe, J.³ Rea, H.H.⁴

6
- 0027980288
- Patterns of increasing η-agonist use and the risk of fatal or near-fatal asthma
- Suissa S, Blais L, Ernst P. Patterns of increasing η-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J 1994;7:1602-1609.
- (1994) Eur Respir J , vol.7 , pp. 1602-1609
- Suissa, S.¹ Blais, L.² Ernst, P.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.